Anne Gry Bentzen
Papers
1
Total Citations
3
H-Index
1
About
Anne Gry Bentzen is a prominent clinical researcher whose work centers on patient-reported outcomes and treatment-related toxicities in prostate cancer care. Her major contributions lie in advancing the understanding of how curative treatments—including prostatectomy, primary radiotherapy, and salvage radiotherapy—affect patients' quality of life. Through rigorous analysis of patient-reported outcome measures (PROMs), she has helped clarify the real-world burden of adverse health outcomes, enabling more informed shared decision-making between clinicians and patients. Her 2023 study on PROMs after contemporary prostate cancer treatments, though recently published, has already garnered 3 citations, reflecting its timely relevance in an era of evolving treatment techniques. Bentzen’s research is particularly notable for addressing study heterogeneity and incorporating modern therapeutic approaches, filling critical gaps in the evidence base. By prioritizing the patient’s voice in oncological outcomes, she has contributed to a paradigm shift toward more holistic, patient-centered care in urologic oncology. Her work continues to guide clinicians in balancing cancer control with long-term quality of life, making her a key voice in prostate cancer survivorship research.
Research Focus
Key Achievements
Top Papers
- 1